BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koprdova R, Csatlosova K, Durisova B, Bogi E, Majekova M, Dremencov E, Mach M. Electrophysiology and Behavioral Assessment of the New Molecule SMe1EC2M3 as a Representative of the Future Class of Triple Reuptake Inhibitors. Molecules 2019;24:E4218. [PMID: 31757051 DOI: 10.3390/molecules24234218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Müller T. Experimental Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of the Evidence. J Exp Pharmacol 2021;13:397-408. [PMID: 33824605 DOI: 10.2147/JEP.S267032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Csatlosova K, Bogi E, Durisova B, Grinchii D, Paliokha R, Moravcikova L, Lacinova L, Jezova D, Dremencov E. Maternal immune activation in rats attenuates the excitability of monoamine-secreting neurons in adult offspring in a sex-specific way. Eur Neuropsychopharmacol 2021;43:82-91. [PMID: 33341344 DOI: 10.1016/j.euroneuro.2020.12.002] [Reference Citation Analysis]
3 Sarapultsev A, Vassiliev P, Grinchii D, Kiss A, Mach M, Osacka J, Balloova A, Paliokha R, Kochetkov A, Sidorova L, Sarapultsev P, Chupakhin O, Rantsev M, Spasov A, Dremencov E. Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects. Int J Mol Sci 2021;22:13626. [PMID: 34948423 DOI: 10.3390/ijms222413626] [Reference Citation Analysis]